Stock NAMS NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NewAmsterdam Pharma Company N.V. Nasdaq

Equities

NAMS

NL00150012L7

Market Closed - Nasdaq
Other stock markets
 13:00:00 2024-07-03 EDT 		5-day change 1st Jan Change
20 USD -1.48% Intraday chart for NewAmsterdam Pharma Company N.V. +3.20% +81.74%
06-11 NewAmsterdam Pharma Gets Another US Patent Extending IP Protection for Obicetrapib Until July 2043 MT
06-10 Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.22B -
BIONTECH SE Stock BioNTech SE
 19.01B -
GENMAB A/S Stock Genmab A/S
 15.71B
  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. NAMS Stock
  5. Charts NewAmsterdam Pharma Company N.V.
  6. Sector Chart